Utility of a Laboratory Alert System for Detecting Adverse Drug Reactions in Hospitalised Patients: Hyponatremia and Rhabdomyolysis

por Valdés-Garicano, Mónica, Mejía-Abril, Gina, Campodónico, Diana, Parra-Garcés, Raúl, Abad-Santos, Francisco
Publicado 2022

Preemptive TPMT Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoim...

por Valdez-Acosta, Sarahí, Zubiaur, Pablo, Casado, Miguel Angel, Novalbos, Jesús, Casajús, Ana, Campodónico, Diana, Oyagüez, Itziar, Abad-Santos, Francisco
Publicado 2023

Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers

por Casajús, Ana, Zubiaur, Pablo, Méndez, Marta, Campodónico, Diana, Gómez, Antía, Navares-Gómez, Marcos, Villapalos-García, Gonzalo, Soria-Chacartegui, Paula, Novalbos, Jesús, Román, Manuel, Mejía-Abril, Gina, Ochoa, Dolores, Abad-Santos, Francisco
Publicado 2022

CYP2C8 *3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride

por Campodónico, Diana María, Zubiaur, Pablo, Soria‐Chacartegui, Paula, Casajús, Ana, Villapalos‐García, Gonzalo, Navares‐Gómez, Marcos, Gómez‐Fernández, Antía, Parra‐Garcés, Raúl, Mejía‐Abril, Gina, Román, Manuel, Martín‐Vílchez, Samuel, Ochoa, Dolores, Abad‐Santos, Francisco
Publicado 2022

The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study)

por Sancho-López, Arantxa, Ruiz-Antorán, Belén, Iglesias Hernangómez, Teresa, Ramírez-García, Almudena, Gómez-Estévez, Irene, Sanabria-Cabrera, Judith, Llop Rius, Roser, Pedrós, Consuelo, Campodonico, Diana, Jiménez-Jorge, Silvia, García Luque, Amelia, Costa Frossad França, Lucienne, Montané, Eva, Aldea-Perona, Ana, Téllez Lara, Nieves, Bosch Ferrer, Montserrat, Rodriguez Jiménez, Consuelo, Bonilla-Toyos, Elvira, Sabín Muñoz, Julia, Avendaño-Solá, Cristina, Blasco Quilez, María Rosario
Publicado 2023